Effects of EGCG and DAC Combinational Treatment on Treating Triple Negative Breast Cancer and Aiding Immune Checkpoint Blockage Therapies

Wang, Zixu.


  • Triple-negative breast cancer (TNBC) is a type of breast cancer that has decreased expression of progesterone receptor (PR) and estrogen receptor (ER), with no overexpression level of human epidermal growth factor receptor 2 (Her2). TNBC is most difficult to treat due to lack of druggable targets, high rates of recurrence and metastasis and resistance to immunotherapy. One of the common changes ... read more
This object is in collection Creator department Thesis Type Genre Permanent URL
To Cite:
TARC Citation Guide    EndNote